The present invention relates to substituted-cyanopyrrolidines of Formula (I) with activity as inhibitors of deubiquitilating enzymes, in particular, ubiquitin C-terminal hydrolase 30 or ubiquitin specific peptidase 30 (USP30), having utility in a variety of therapeutic areas including cancer and conditions involving mitochondrial dysfunction. (I)
本发明涉及式(I)的取代-
氰基
吡咯烷,其具有作为去泛素化酶,特别是泛素C-末端
水解酶30或泛素特异性肽酶30(U
SP30)的
抑制剂的活性,可用于各种治疗领域,包括癌症和涉及线粒体功能障碍的疾病。(I)